After we discussed the background of the share selection of 8 values in the 3 actively supervised boxes from WH Selfinvest, we focused on some exciting individual values and analyzed the corresponding chart image in addition to the news.
Starting with one of the Investor favorites Palantir and their new cooperation in the finance and medical area, another high is shown. The evaluation with a KGV of over 400 has already gone very far, but the AI value is also assessed by many authorities and now also companies as currently unrivaled. Of course, this data must also be protected, like everything in the cloud, so that another investor favorite is represented in both boxes with crowdstrike. The company shows a weakened, but continued robust growth and implements further AI functions in its security platform. This is intended to seal long -term growth – the stock is about to be a new all -time high.
Until then, Zscaler still needs a piece of distance, but the youngest upward movement is impressive. After a successful takeover, the AI topic in the cloud share is further fuel for price increases.
With increasing listings in Bitcoin, Strategy can also continue to increase. The company continues to buy at the cryptom market and currently keep around 582,000 Bitcoin in the balance sheet. This currently leads to joy with this positive development of the asset class.
The new films and series with millions of users are also delighted: on the inside of Netflix. In the future, formats will also be produced in Spain and the current blockbuster by Matthias Schweighöfer inspires the domestic audience, so that specific content provides further interest in many countries.
Don’t be afraid of the effort in tax returns and other formalities as a customer of intuit. The software specialist integrates further AI applications into its processes and thus increases efficiency and waiting times in the form of form. That is great on the market!
We speculate on bad news or subsequent balance sheet data with the short box. As a representative, Regeneron stands out in the box, which cannot receive an important approval because test results were below expectations. In addition, some patents and thus also potential sales in the next quarters expire.
You can find out again about the following links how you can have all the values fully automated on freestoxx.